Autonomic and Respiratory Consequences of Altered Chemoreflex Function: Clinical and Therapeutic Implications in Cardiovascular Diseases
European Journal of Heart Failure · 2023
DOI: 10.1002/ejhf.2819 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Heart Failure, 2023. Verfasst von Alberto Giannoni und 11 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Failure. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
The importance of chemoreflex function for cardiovascular health is increasingly recognized in clinical practice. The physiological function of the chemoreflex is to constantly adjust ventilation and circulatory control to match respiratory gases to metabolism. This is achieved in a highly integrated fashion with the baroreflex and the ergoreflex. The functionality of chemoreceptors is altered in cardiovascular diseases, causing unstable ventilation and apnoeas and promoting sympathovagal imbalance, and it is associated with arrhythmias and fatal cardiorespiratory events. In the last few years, opportunities to desensitize hyperactive chemoreceptors have emerged as potential options for treatment of hypertension and heart failure. This review summarizes up to date evidence of chemoreflex physiology/pathophysiology, highlighting the clinical significance of chemoreflex dysfunction, and lists the latest proof of concept studies based on modulation of the chemoreflex as a novel target in cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
- Fondazione Toscana G. Monasterio, Pisa, Italy.
- University of Aachen, Aachen, Germany.
- IRCCS Policlinico San Donato, Milano, Italy.
- Department of Neurology, University of Iowa, Iowa City, IA, USA.
- Division of Cardiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Förderung
- NINDS NIH HHS
Zitieren
APA
Giannoni, A., Borrelli, C., Gentile, F., Sciarrone, P., Spießhöfer, J., Piepoli, M., Richerson, G. B., Floras, J. S., Coats, A. J. S., Javaheri, S., Emdin, M., & Passino, C. (2023). Autonomic and Respiratory Consequences of Altered Chemoreflex Function: Clinical and Therapeutic Implications in Cardiovascular Diseases. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.2819
Vancouver
Giannoni A, Borrelli C, Gentile F, Sciarrone P, Spießhöfer J, Piepoli M, et al. Autonomic and Respiratory Consequences of Altered Chemoreflex Function: Clinical and Therapeutic Implications in Cardiovascular Diseases. European Journal of Heart Failure. 2023. doi:10.1002/ejhf.2819
BibTeX
@article{Giannoni2023,
author = {Giannoni, Alberto and Borrelli, Chiara and Gentile, Francesco and Sciarrone, Paolo and Spießhöfer, Jens and Piepoli, Massimo and Richerson, George B and Floras, John S and Coats, Andrew J S and Javaheri, Shahrokh and Emdin, Michele and Passino, Claudio},
title = {Autonomic and Respiratory Consequences of Altered Chemoreflex Function: Clinical and Therapeutic Implications in Cardiovascular Diseases},
journal = {European Journal of Heart Failure},
year = {2023},
doi = {10.1002/ejhf.2819}
}
EUVIMED